loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Drug Master Files (DMF) of Ixazomib Citrate Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MSN Laboratories (1)

02 Sun Pharmaceutical Industries Limited (1)

filter

01 IXAZOMIB CITRATE (2)

filter

01 India (2)

filter

01 Active (2)

filter

01 Complete (1)

02 Blank (1)

URL Supplier Web Content
33533
Active
2019-01-31
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
34048
Active
2019-09-19
Complete
2019-11-05
2019-09-12
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1239908-20-3 / Ixazomib Citrate API manufacturers, exporters & distributors?

Ixazomib Citrate manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of Ixazomib Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ixazomib Citrate manufacturer or Ixazomib Citrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ixazomib Citrate manufacturer or Ixazomib Citrate supplier.

PharmaCompass also assists you with knowing the Ixazomib Citrate API Price utilized in the formulation of products. Ixazomib Citrate API Price is not always fixed or binding as the Ixazomib Citrate Price is obtained through a variety of data sources. The Ixazomib Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ixazomib Citrate

Synonyms

1239908-20-3, Ixazomib citrate (ester), Ixazomib citrate [usan], 46cwk97z3k, 2-[4-(carboxymethyl)-2-[(1r)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid, Unii-46cwk97z3k

Cas Number

1239908-20-3

Unique Ingredient Identifier (UNII)

46CWK97Z3K

About Ixazomib Citrate

Ixazomib Citrate is the citrate salt form of ixazomib, an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.

Ixazomib Citrate Manufacturers

A Ixazomib Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ixazomib Citrate, including repackagers and relabelers. The FDA regulates Ixazomib Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ixazomib Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ixazomib Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ixazomib Citrate Suppliers

A Ixazomib Citrate supplier is an individual or a company that provides Ixazomib Citrate active pharmaceutical ingredient (API) or Ixazomib Citrate finished formulations upon request. The Ixazomib Citrate suppliers may include Ixazomib Citrate API manufacturers, exporters, distributors and traders.

click here to find a list of Ixazomib Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ixazomib Citrate USDMF

A Ixazomib Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ixazomib Citrate active pharmaceutical ingredient (API) in detail. Different forms of Ixazomib Citrate DMFs exist exist since differing nations have different regulations, such as Ixazomib Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ixazomib Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Ixazomib Citrate USDMF includes data on Ixazomib Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ixazomib Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ixazomib Citrate suppliers with USDMF on PharmaCompass.

Ixazomib Citrate Manufacturers | Traders | Suppliers

Ixazomib Citrate Manufacturers, Traders, Suppliers 1
85

We have 2 companies offering Ixazomib Citrate

Get in contact with the supplier of your choice:

  1. MSN Laboratories
  2. Sun Pharmaceutical Industries Limited
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY